| Authors: |
Thomas JS; Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA., Siu LL; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Ingham M; Columbia University Irving Medical Center, New York, NY, USA., Azad NS; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA., Meyer CF; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA., Olszanski AJ; Fox Chase Cancer Center, Philadelphia, PA, USA., Whalen GF; University of Massachusetts Memorial Medical Center, Worcester, MA, USA., Camacho LH; Center for Oncology and Blood Disorders, Houston, TX, USA., Hu JS; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Hanna DL; Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA., Cheng PM; Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA., Abdul Razak AR; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Abbate F; Intensity Therapeutics, Inc., Shelton, CT, USA., Mahmood S; Intensity Therapeutics, Inc., Shelton, CT, USA., Walters IB; Intensity Therapeutics, Inc., Shelton, CT, USA., Bender LH; Intensity Therapeutics, Inc., Shelton, CT, USA., El-Khoueiry AB; Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA. Electronic address: elkhouei@med.usc.edu. |
